Mosquito 发表于 2025-3-21 19:55:31

书目名称New Therapies in Advanced Cutaneous Malignancies影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0665855<br><br>        <br><br>书目名称New Therapies in Advanced Cutaneous Malignancies读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0665855<br><br>        <br><br>

抵押贷款 发表于 2025-3-21 22:15:23

http://reply.papertrans.cn/67/6659/665855/665855_2.png

染色体 发表于 2025-3-22 02:15:29

http://reply.papertrans.cn/67/6659/665855/665855_3.png

急性 发表于 2025-3-22 07:53:55

Sonidegibn the EU and additionally for patients who have recurred following surgery or radiation therapy in the United States. The efficacy and safety of sonidegib have been demonstrated in phase I and phase II clinical trials.

不易燃 发表于 2025-3-22 10:58:13

Nivolumab in Melanoma: An Overview of Medical Literature and Future Perspectivesment of stage IIIB–IIIC/stage IV melanoma in 2017 on the basis of an improvement in recurrence-free survival versus the active comparator ipilimumab. In this chapter, we review the activity, efficacy, and toxicity of nivolumab and summarize new potential therapeutic strategies, which could potentially expand its spectrum of activity in melanoma.

micronutrients 发表于 2025-3-22 13:11:12

http://reply.papertrans.cn/67/6659/665855/665855_6.png

狗窝 发表于 2025-3-22 20:03:18

http://reply.papertrans.cn/67/6659/665855/665855_7.png

Vital-Signs 发表于 2025-3-22 22:35:10

http://reply.papertrans.cn/67/6659/665855/665855_8.png

Axon895 发表于 2025-3-23 04:08:45

Pathology of Melanoma and Skin Carcinomasial role in patient management and prognosis. Cutaneous melanomas, together with carcinomas, represent a majority of skin neoplasms. We have based this chapter on the fourth edition of the World Health Organization classification of Skin Tumours, published in 2018. The development of each malignancy

令人作呕 发表于 2025-3-23 09:08:11

http://reply.papertrans.cn/67/6659/665855/665855_10.png
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: New Therapies in Advanced Cutaneous Malignancies; Piotr Rutkowski,Mario Mandalà Book 2021 The Editor(s) (if applicable) and The Author(s),